http://www.sierraoncology.com
Sierra Oncology, Inc. Company Intro
Sierra Oncology is an ambitious clinical stage drug development company, advancing targeted therapies for treating cancer patients.
Industry
Healthcare
Sierra Oncology, Inc. Headquaters
885 West Georgia Street
Vancouver,V6C 3E8
Canada
Sierra Oncology, Inc. Share price
17 May 2023 13:56 GMT
$0
0.0 (0 %)
Sierra Oncology, Inc. Market cap
$
WMC RANKING
2024
Sierra Oncology, Inc. # 325
BiotechnologyLatest Sierra Oncology, Inc. News
12 Feb 2024
PARP Inhibitors Market Size
PARP inhibitors market is poised for remarkable expansion, with projections surpassing a US$ 8.43 Billion by 2026, as reported by FMI.
12 Feb 2024
PARP Inhibitors Market Size
PARP inhibitors market is poised for remarkable expansion, with projections surpassing a US$ 8.43 Billion by 2026, as reported by FMI.
12 Feb 2024
PARP Inhibitors Market Size
PARP inhibitors market is poised for remarkable expansion, with projections surpassing a US$ 8.43 Billion by 2026, as reported by FMI.
WMC Market Score
WMC Market to Revenue Score
Sierra Oncology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Sierra Oncology, Inc. | USD | $300 | $68,924 | $-68,905 | $ 0.00 | 325 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Sierra Oncology, Inc. Social Followers vs Top 4 Industry Competitors
Sierra Oncology, Inc. Post vs Top 4 Industry Competitors
Sierra Oncology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Sierra Oncology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Sierra Oncology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Sierra Oncology, Inc. | 0.00 | 0.33 | 0.01 | 0 | 0 | 0 | 0.12 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
